Faes Farma, S.A. (FAE.MC)
- Previous Close
4.0150 - Open
4.0500 - Bid 4.1200 x --
- Ask 4.1400 x --
- Day's Range
4.0450 - 4.1600 - 52 Week Range
3.2500 - 4.1600 - Volume
746,552 - Avg. Volume
974,742 - Market Cap (intraday)
1.282B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
11.44 - EPS (TTM)
0.3600 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 0.08 (2.04%)
- Ex-Dividend Date Jan 9, 2025
- 1y Target Est
4.28
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
faesfarma.com1,775
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: FAE.MC
View More
Performance Overview: FAE.MC
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FAE.MC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FAE.MC
View MoreValuation Measures
Market Cap
1.25B
Enterprise Value
1.20B
Trailing P/E
11.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.54
Price/Book (mrq)
1.72
Enterprise Value/Revenue
2.43
Enterprise Value/EBITDA
9.35
Financial Highlights
Profitability and Income Statement
Profit Margin
21.83%
Return on Assets (ttm)
8.33%
Return on Equity (ttm)
15.99%
Revenue (ttm)
510.04M
Net Income Avi to Common (ttm)
111.36M
Diluted EPS (ttm)
0.3600
Balance Sheet and Cash Flow
Total Cash (mrq)
72.14M
Total Debt/Equity (mrq)
3.62%
Levered Free Cash Flow (ttm)
45.97M